Tag: Over-the-Counter Drugs and Devices

Displaying 1 - 20 of 107 results.

Pages

The Federal Trade Commission announced that 30 more marketers nationwide have stopped making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus. The marketers removed these claims after receiving FTC warning letters...
In testimony today before the Senate Commerce Committee’s Subcommittee on Consumer Protection, Product Safety, and Data Security, the Federal Trade Commission provided an update on its work to protect consumers from scams and frauds related to the COVID-19 pandemic.
In April 2021, the FTC charged St. Louis-based chiropractor Eric Anthony Nepute and his company Quickwork LLC with violating the COVID-19 Consumer Protection Act and the Federal Trade Commission Act, by deceptively marketing products containing vitamin D and zinc as scientifically...
Note: The FTC hosted a media call-in on this announcement with Andrew Smith, Director, Bureau of Consumer Protection on Thursday, December 17, 2020.  
In December 2020, the FTC announced its first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The Commission took action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported...
In December 2020, the FTC announced its first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The Commission took action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported...
In December 2020, the FTC announced its first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The Commission took action against six sellers of CBD-containing products for allegedly making a wide range of scientifically unsupported...
The Federal Trade Commission is sending checks totaling $774,755 to 13,221 consumers who bought Synovia, a supplement advertised and sold by A.S. Research, LLC as a treatment for arthritis and joint pain. The average refund amount is $58.60 per consumer.
The Federal Trade Commission announced it has sent letters warning 20 more marketers nationwide to stop making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus. This is the ninth set of warning letters the FTC has...
The Federal Trade Commission is sending 4,782 checks totaling $76,368.54 to consumers who bought Isoprex, a supposed “miracle” pain supplement marketed to older Americans nationwide.
The Federal Trade Commission is sending 12,219 checks totaling more than $110,000 to consumers who bought StimTein, a pill that would supposedly provide effective joint pain relief.
The Federal Trade Commission is sending 70,142 checks and PayPal payments totaling $3,864,824 to consumers nationwide who bought Quell, a wearable device that supposedly would treat chronic pain throughout the body when placed below the knee.

Pages